KERENDIA is COVERED on some of the largest Commercial and Medicare Part D formularies in the nation, covering over 150 million lives¹
There are 2 savings offers available to help your eligible patients start and stay on KERENDIA:
*Patients are eligible if they are commercially insured and may pay as little as $0 and save up to $3000 per year. Patients who are enrolled in any type of government insurance or reimbursement programs are not eligible. Full terms and conditions apply, see www.KERENDIAsavings.com
†Terms and conditions apply. Call 1-888-KERENDIA (537-3634) or visit www.KERENDIAsavings.com for more information.
It is easy to get or activate a KERENDIA Savings Card or KERENDIA Free Trial Voucher.
Please provide the $0 KERENDIA Savings Card and/or KERENDIA Free Trial Voucher to your patients and instruct them to activate the card and take it to the pharmacy with their KERENDIA prescription.
Here are additional resources you may find helpful to gain patient access to KERENDIA:
We provide visibility into the entire patient journey and reduce time to therapy through enhanced services within your workflow:
Log in to or create your account at CoverMyMeds.com to help your patients start KERENDIA today.
Patients who need help paying for their KERENDIA prescription should call 1-888-KERENDIA (537-3634) or visit www.KERENDIA.com to learn more about the affordability solutions offered by Bayer.
‡CoverMyMeds® is an independent party.
You may also contact Access Services by Bayer for support at 1-800-288-8374
The Bayer US Patient Assistance Foundation is a charitable organization that helps eligible patients get their Bayer prescription medicine at no cost. Please have your patient contact the program at 1-866-2BUSPAF (228-7723) Monday–Friday, 9:00 am–6:00 pm EST, or visit the foundation website at www.patientassistance.bayer.us to see if they might qualify for assistance.
KERENDIA is indicated to reduce the
risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D)
Measure serum potassium periodically during treatment with KERENDIA and adjust dose accordingly. More frequent monitoring may be necessary for patients at risk for hyperkalemia, including those on concomitant medications that impair potassium excretion or increase serum potassium
Please read the Prescribing Information for KERENDIA.
References: 1. Data on file. Bayer.